Announcements Trials
Browse Landscape

Status

Temporarily not available 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 6Expanded_access 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1

Conditions

Uterine Neoplasms 1Uterine Cervical Neoplasms 1Sarcoma, Ewing 1Ovarian Neoplasms 1

Interventions

tazemetostat 2regorafenib 2nirogacestat 2avapritinib 2Trabectedin 2selinexor 1ripretinib 1omburtamab I-131 1olaratumab 1mifamurtide 1glucarpidase 1ganitumab 1fludarabine phosphate 1balstilimab 1anlotinib 1Whole-Body Irradiation 1Tacrolimus 1TH 302 1Sunitinib 1Proton Pump Inhibitors 1Mycophenolic Acid 1Imatinib Mesylate 1Hydrocortisone 1FANG vaccine 1Everolimus 1DOXO-EMCH 1Cytarabine 1Cord Blood Stem Cell Transplantation 1Carboxypeptidases 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Expanded_access × FANG vaccine × Sarcoma × Clear all
NCT03842865 2025-06-05

Expanded Access of Vigil in Solid Tumors

Gradalis, Inc.

Temporarily not available
GynecologicSarcoma

Uterine Cervical Neoplasms, Ovarian Neoplasms, Sarcoma, Ewing, Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡